A phase II proof-of-concept study of PUR-1800 in patients with chronic obstructive pulmonary disease (COPD)
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2018
At a glance
- Drugs PUR 1800 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Proof of concept; Therapeutic Use
- 07 Jun 2018 According to a Pulmatrix media release, this study is expected to start next year.
- 30 Oct 2017 According to a Pulmatrix media release, this study is expected to begin in 2H 2018.
- 08 Aug 2017 New trial record